Our study elucidates that genetically proxied PCSK9 inhibition is inversely associated with psoriatic arthritis susceptibility, underscoring the therapeutic potential of extant PCSK9 inhibitors. The gene discussed is PCSK9; the disease is psoriatic arthritis.